Russell Investments Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,111
| Closed | -$16.4K | – | 3669 |
|
|
2024
Q1 | $16.4K | Buy |
1,111
+45
| +4% | +$665 | ﹤0.01% | 2796 |
|
|
2023
Q4 | $14.3K | Buy |
1,066
+202
| +23% | +$2.71K | ﹤0.01% | 2785 |
|
|
2023
Q3 | $10.7K | Buy |
+864
| New | +$10.7K | ﹤0.01% | 2985 |
|
|
2019
Q1 | – | Sell |
-5,974
| Closed | -$18K | – | 3127 |
|
|
2018
Q4 | $18K | Hold |
5,974
| – | – | ﹤0.01% | 2870 |
|
|
2018
Q3 | $25K | Sell |
5,974
-128,833
| -96% | -$539K | ﹤0.01% | 2901 |
|
|
2018
Q2 | $521K | Sell |
134,807
-509
| -0.4% | -$1.97K | ﹤0.01% | 2378 |
|
|
2018
Q1 | $857K | Buy |
135,316
+17,138
| +15% | +$109K | ﹤0.01% | 2268 |
|
|
2017
Q4 | $982K | Buy |
+118,178
| New | +$982K | ﹤0.01% | 2168 |
|